Optinose to Showcase Developments at Key Healthcare Forum
YARDLEY, Pa. — In an impactful announcement, Optinose (NASDAQ:OPTN), a leading pharmaceutical company dedicated to addressing patient needs in ear, nose, and throat (ENT) and allergy care, has revealed its management team will present significant company insights and updates at the prestigious Piper Sandler 36th Annual Healthcare Conference.
Event Details and Timing
This noteworthy presentation is scheduled for December 5, 2024, at 1:30 p.m. ET. Stakeholders and interested parties are encouraged to join the discussion during this time to gain valuable insights directly from the company’s leadership.
Webcast Access
For those unable to attend in person, Optinose will offer a live webcast of the presentation. Interested individuals can find further information on how to access the webcast by visiting the Investors section of the Optinose website. This commitment ensures that even those unable to participate live will have the opportunity to engage with the content presented.
Understanding Optinose's Mission and Offerings
At the core of Optinose’s operations lies a focus on enhancing clinical outcomes for patients supported by ENT specialists and allergists. The company seeks to revolutionize treatment approaches through innovative solutions tailored for complex health issues faced by these patient populations.
Innovative Developments in Patient Care
Optinose’s commitment to patient-centric healthcare is reflected in its ongoing research and development initiatives. The company is dedicated to providing cutting-edge therapies that are designed with the patient’s needs in mind, ensuring that treatments are not only effective but also accessible.
Engagement with Medical Professionals
Through its participation at the annual conference, Optinose aims to strengthen its relationship with healthcare providers, communicate its latest advancements, and discuss potential collaborations that align with its mission to improve patient outcomes in the ENT and allergy sectors.
Connecting with Optinose
Further engagement and updates about the company can be found on their official website, where stakeholders can learn more about their innovative product lineup and commitment to patient care.
Investor Relations and Requests
For those inquiring about investment opportunities or needing further information concerning the company’s operations, the Investor Contact for Optinose is Jonathan Neely. Interested parties may reach Jonathan via email or phone. This openness ensures that investors can stay informed about the company’s developments and strategic direction.
Frequently Asked Questions
What is the primary focus of Optinose?
Optinose primarily focuses on developing treatments for patients seen by ear, nose, and throat specialists and allergists.
Where can I access the presentation?
The presentation will be accessible via a live webcast on the Investors page of the Optinose website.
What date is the Piper Sandler Healthcare Conference scheduled for?
The conference is set to take place on December 5, 2024.
Who can I contact for more information about investments in Optinose?
Investors can reach out to Jonathan Neely for inquiries about investments.
How does Optinose engage with healthcare professionals?
Optinose engages with medical professionals through events like the Piper Sandler Conference to discuss advancements and potential partnerships in patient care.
